[go: up one dir, main page]

GB201905100D0 - Polypeptides and methods of use - Google Patents

Polypeptides and methods of use

Info

Publication number
GB201905100D0
GB201905100D0 GBGB1905100.2A GB201905100A GB201905100D0 GB 201905100 D0 GB201905100 D0 GB 201905100D0 GB 201905100 A GB201905100 A GB 201905100A GB 201905100 D0 GB201905100 D0 GB 201905100D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1905100.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antibody Innovation Ltd
Original Assignee
Antibody Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antibody Innovation Ltd filed Critical Antibody Innovation Ltd
Priority to GBGB1905100.2A priority Critical patent/GB201905100D0/en
Publication of GB201905100D0 publication Critical patent/GB201905100D0/en
Priority to PCT/GB2020/050940 priority patent/WO2020208372A1/en
Priority to EP20728119.7A priority patent/EP3953381A1/en
Ceased legal-status Critical Current

Links

GBGB1905100.2A 2019-04-10 2019-04-10 Polypeptides and methods of use Ceased GB201905100D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1905100.2A GB201905100D0 (en) 2019-04-10 2019-04-10 Polypeptides and methods of use
PCT/GB2020/050940 WO2020208372A1 (en) 2019-04-10 2020-04-09 Fusion protein comprising nanoluciferase inserted between immunoglobulin variable domains
EP20728119.7A EP3953381A1 (en) 2019-04-10 2020-04-09 Fusion protein comprising nanoluciferase inserted between immunoglobulin variable domains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1905100.2A GB201905100D0 (en) 2019-04-10 2019-04-10 Polypeptides and methods of use

Publications (1)

Publication Number Publication Date
GB201905100D0 true GB201905100D0 (en) 2019-05-22

Family

ID=66379939

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1905100.2A Ceased GB201905100D0 (en) 2019-04-10 2019-04-10 Polypeptides and methods of use

Country Status (3)

Country Link
EP (1) EP3953381A1 (en)
GB (1) GB201905100D0 (en)
WO (1) WO2020208372A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877898B2 (en) 2010-04-30 2014-11-04 Stc.Unm Fluorescent fusion polypeptides and methods of use
US20150253338A1 (en) 2006-03-09 2015-09-10 Hoffmann-La Roche Inc. Anti-drug antibody assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9517257B2 (en) * 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
AU2017241591A1 (en) * 2016-03-28 2018-10-18 The Charles Stark Draper Laboratory, Inc. Bacteria identification and antibiotic susceptibility profiling device
US20190169308A1 (en) * 2016-04-22 2019-06-06 Alligator Bioscience Ab Novel bispecific polypeptides against cd137

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150253338A1 (en) 2006-03-09 2015-09-10 Hoffmann-La Roche Inc. Anti-drug antibody assay
US8877898B2 (en) 2010-04-30 2014-11-04 Stc.Unm Fluorescent fusion polypeptides and methods of use
US9566353B2 (en) 2010-04-30 2017-02-14 Stc.Unm Fluorescent fusion polypeptides and methods of use

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
GENG, D., J. PHARM. BIOMED. ANAL., vol. 39, 2005, pages 364 - 375
HAMERS-CASTERMAN ET AL., NATURE, vol. 363, no. 6428, 1993, pages 446 - 448
HOESEL ET AL., ANT-DRUG ANTIBODY ASSAY, vol. 43
KALIYAPERUMAL, A.JING, S., CURR. PHARM. BIOTECHNOL, vol. 10, 2009, pages 352 - 358
MARKIV AANANI BDURVASULA RVKANG AS: "Module based antibody engineering: a novel synthetic REDantibody", J IMMUNOL METHODS, vol. B64, no. 1-2, 1 February 2011 (2011-02-01), pages 40 - 9, XP027583512
MARKIV ABEATSON RBURCHELL JDURVASULA RVKANG AS: "Expression of recombinant multicoloured fluorescent antibodies in gor -/ trxB- E. coli cytoplasm", BMC BIOTECHNOL., vol. 11, no. 1, 30 November 2011 (2011-11-30), pages 117, XP021130658, DOI: doi:10.1186/1472-6750-11-117
MEENU WADHWAIVANA KNEZEVICHYE-NA KANGROBIN THORPE: "Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility", BIOLOGICALS, vol. 43, no. 5, 2015, pages 298 - 306, XP029269961, DOI: doi:10.1016/j.biologicals.2015.06.004
MIRE-SLUIS ARBARRETT YCDEVANARAYAN VKEREN ELIU HMAIA MPARISH TSCOTT GSHANKAR GSHORES E: "Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products", J IMMUNOL METHODS, vol. 289, no. 1-2, June 2004 (2004-06-01), pages 1 - 16, XP004520874, DOI: doi:10.1016/j.jim.2004.06.002
MIRE-SLUIS, A.R., J. IMMUNOL. METHODS, vol. 289, 2004, pages 1 - 16
NATH NHEMMING RGODAT 8URH M: "Development of NanoLuc bridging immunoassay for detection of anti-drug antibodies", J IMMUNOL METHODS, vol. 450, November 2017 (2017-11-01), pages 17 - 26, XP085187523, DOI: doi:10.1016/j.jim.2017.07.006
SHALINI GUPTAVISWANATH DEVANARAYANDEBORAH FINCOGEORGE R: "Gunn III, Susan Kirshner, Susan Richards, Bonita Rup, An Song, Meena Subramanyam. Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 55, no. 5, 2011, pages 878 - 888
WORNPLUCKTHUN, J MOL BIO!, vol. 305, no. 5, 2001, pages 989 - 1010

Also Published As

Publication number Publication date
EP3953381A1 (en) 2022-02-16
WO2020208372A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
GB2595606B (en) CRISPR-Cas effector polypeptides and methods of use thereof
IL287720A (en) Modulators of thr-beta and methods of use thereof
IL276731A (en) Anti-cd73 antibodies and methods of use thereof
IL278821A (en) Anti-sirpa antibodies and methods of use thereof
IL272332A (en) Antigen-presenting polypeptides and methods of use thereof
SG11202010909RA (en) Anti-msr1 antibodies and methods of use thereof
IL280102A (en) Pd1-4-1bbl variant fusion protein and methods of use thereof
SG11202101436SA (en) Anti-her2 polypeptides and methods of use thereof
IL279648A (en) Anti-sirp-beta1 antibodies and methods of use thereof
SG11202108734VA (en) Anti-trem2 antibodies and methods of use thereof
PT3618928T (en) Anti-sortilin antibodies and methods of use thereof
IL280103A (en) Sirpalpha-4-1bbl variant fusion protein and methods of use thereof
SG11202108403UA (en) Anti-clec2d antibodies and methods of use thereof
IL293616B1 (en) Alkaline phosphatase polypeptides and methods of use thereof
SG11202112978WA (en) Auto-injector and related methods of use
IL283387A (en) Diarylhydantoin compounds and methods of use thereof
IL277212A (en) Anti-klk5 antibodies and methods of use
IL277963A (en) Bicyclic carboxamides and methods of use thereof
IL290741A (en) Anti-cd96 antibodies and methods of use thereof
IL289952A (en) Anti-ms4a4a antibodies and methods of use thereof
IL280338A (en) Anti-siglec-5 antibodies and methods of use thereof
GB2600592B (en) Polypeptide and use thereof
IL283884A (en) Anti-il-36 antibodies and methods of use thereof
IL276053A (en) Therapeutic-gard and method of use thereof
IL291461A (en) Anti-alpha-synuclein antibodies and methods of use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)